Altamira Therapeutics Ltd. Files 6-K Report
Ticker: CYTOF · Form: 6-K · Filed: Mar 10, 2025 · CIK: 1601936
Sentiment: neutral
Topics: 6-K, corporate-update, foreign-private-issuer
Related Tickers: ALTA
TL;DR
Altamira Therapeutics (ALTA) filed a 6-K, just a routine update. Nothing major here.
AI Summary
Altamira Therapeutics Ltd. filed a Form 6-K on March 10, 2025, reporting its status as a foreign private issuer. The company, formerly known as Auris Medical Holding Ltd., is incorporated in Bermuda and its principal executive offices are located in Hamilton. Altamira Therapeutics AG, a wholly-owned subsidiary, was previously named Auris Medical AG.
Why It Matters
This filing provides routine corporate updates and confirms the company's reporting status, which is important for investors tracking its regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a standard report of foreign private issuer status and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Altamira Therapeutics Ltd. (company) — Registrant
- Auris Medical Holding Ltd. (company) — Former company name
- Altamira Therapeutics AG (company) — Wholly-owned subsidiary
- Auris Medical AG (company) — Former name of subsidiary
- March 10, 2025 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report its status as a foreign private issuer for the month of March 2025.
What was Altamira Therapeutics Ltd. previously known as?
Altamira Therapeutics Ltd. was formerly known as Auris Medical Holding Ltd.
Where are Altamira Therapeutics Ltd.'s principal executive offices located?
Its principal executive offices are located at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda.
Is Altamira Therapeutics Ltd. required to file annual reports under Form 20-F or Form 40-F?
Yes, the company indicates it files annual reports under cover of Form 20-F.
When did the name change from Auris Medical Holding Ltd. to Altamira Therapeutics Ltd. occur?
The filing indicates a name change date of March 18, 2019, from Auris Medical Holding Ltd.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 10, 2025 regarding Altamira Therapeutics Ltd. (CYTOF).